Peer Review channel feed – Endpoints News

Peer Review channel feed

Biogen vet jumps to CSO at Third Rock Treg biotech; Karuna CEO is stepping down, but this isn't goodbye

3 years ago

Philip Tagari switches Amgen's discovery lab for insitro's machine learning tools; CEO Joaquin Duato to chair J&J's board

3 years ago

Oxford Biomedica's next CEO to start in March; Kåre Schultz ready to wrap up Teva tenure early

3 years ago

Ex-Rubius CEO dusts himself off at a different Flagship biotech; Hutchmed switches things up during pipeline refocus

3 years ago

Fourth time's the charm? bluebird picks up new finance chief; New CEOs here and there

3 years ago

After a one-year gap, Sage finally finds new CMO; Gutted by layoffs, Flagship's Rubius reshuffles a not-so-full deck

3 years ago

Two Aurinia execs are out — and CRISPR’s operations chief isn't far behind; Biogen MS leader jumps to Eli Lilly partner

3 years ago

Former Allergan exec heads to Revance as it challenges Botox; Mark Pruzanski surrounds himself with more teammates

3 years ago

'Been through a lot': New Passage Bio CEO talks about 'rising tide'; Back in business with the FDA, BioMarin finds itself without a CMO

3 years ago

Sanofi's BD chief heads to Owkin as CBO; Roche relies on its bench for Thomas Schinecker’s diagnostics replacement

3 years ago

'Don't eat me' upstart taps Takeda vet on path to the clinic; Greg Mayes leaves Antios for Canadian psychedelics player

3 years ago

Amid massive turnover, Agios hires Biogen alum as new CFO; Scholar Rock, Everest Medicines lead the big CEO parade

3 years ago

Scorpion snags a Sanofi vet to lead the way to the clinic; All eyes on eli-cel as bluebird seeks a finance leader — again

3 years ago

Homology sails with same captains in different seats; Ex-Harpoon chief weathers the Storm at UK biotech

3 years ago

Jay Bradner’s NIBR exit sets off a succession plan at Merck; Dyne and MorphoSys fill major R&D roles

3 years ago

No Myth: CEO of ADC upstart calls it quits; Bristol Myers vet Jon Wigginton scales new heights at Bright Peak

3 years ago

Just like starting over: Moderna tees up another CFO; Geoffrey Porges puts down his SVB pen to join Schrödinger

3 years ago

As Covid program advances, Enanta's new CMO says it's not 'limited to antivirals'; With all eyes on Gilead-partnered cancer drugs, Arcus brings medical chief on board

3 years ago

Astellas taps seasoned CMO amid shift to oncology; Doug Manion steps into a new Arena following $6.7B buyout

3 years ago

Former eGenesis CEO joins vTv as it tries to make a comeback; Eisai nabs Alzheimer’s commercial exec amid lecanemab push

3 years ago

Ex-Moderna commercial leader lands at Celsion as CEO; Schwan song: Changing of the guard at Roche to take effect next year

3 years ago

Former Spark exec to lead a gene therapy upstart of his own; Big Pharma marketing vet named CEO of Swiss biotech

3 years ago

Entos lures former Plexxikon CEO to guide push toward the clinic; Ex-Bristol Myers immunology chief finds new home

3 years ago

Swatting away a takeover attempt, Zymeworks keeps retooling staff; After Cygnal-ing her exit from Flagship, Pearl Huang starts afresh

3 years ago

First page Previous page 3 4 567 8 9 Next page Last page